January 14, 2019
A new study finds a causal link between prescribed opioid treatment during pregnancy and birth defects in newborns.
Researchers found a link between opioid painkillers use just before or during pregnancy and birth defects in a growing fetus.
Birth Defects and Opioids
Two to three percent of participating mothers in the CDC study reported treatment with opioid painkillers just before or during early pregnancy. The reasons for treatment included surgical procedures, infections, chronic diseases, injuries, and other reasons. Researchers found opioid treatment in these periods was associated with several defects including congenital heart disease, which are contributors to infant health and death rates. In addition, treatment with opioid pain relievers was linked to:
Drug manufacturers tried to convince doctors and regulators that opioids were safe for effective for long-term use while ignoring the dangerous side effects such as addiction, overdose, and even death. They did this with misleading articles and advertisements that downplay the dangerous side effects of opioids. Likewise, drugmakers often use respected “thought leaders” who encourage overprescribing and drug benefits.
How Waters Kraus Paul & Siegel Can Help
The opioid lawyers at Waters Kraus Paul & Siegel represent families who have been affected by opioid use and hold pharmaceutical companies responsible for opioid-induced illness. If you took prescription opioids during pregnancy and you are now raising a child with a birth defect including spina bifida, hydrocephaly, glaucoma, gastroschisis, and congenital heart defects, contact an opioid lawyer to have your potential opioid lawsuit reviewed. Email us or call 800.226.9880.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win.
